Get started
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP

BLUEPRINT MEDICINES CORP

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast

1BPMC chart


Full chart

1BPMC upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.99 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.28 EUR
Net income (FY)
‪−64.81 M‬ EUR
Revenue (FY)
‪491.51 M‬ EUR
Shares float
‪63.30 M‬
Beta (1Y)
1.37

Employees


Employees (FY)
649
Change (1Y)
−6 −0.92%
Revenue / Employee (1Y)
‪757.34 K‬ EUR
Net income / Employee (1Y)
‪−99.86 K‬ EUR

About Blueprint Medicines Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Kathryn Haviland
Website
blueprintmedicines.com
Headquarters
Cambridge
Founded
2008
FIGI
BBG01TNWK140
Blueprint Medicines Corp. is a precision therapy company, which engages in the provision of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1BPMC news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as 1BPMC.

Frequently Asked Questions


The current price of 1BPMC is 89.52 EUR — it has increased by 14.65% in the past 24 hours. Watch BLUEPRINT MEDICINES CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange BLUEPRINT MEDICINES CORP stocks are traded under the ticker 1BPMC.
1BPMC stock has risen by 15.06% compared to the previous week, the month change is a 15.06% rise, over the last year BLUEPRINT MEDICINES CORP has showed a 15.06% increase.
We've gathered analysts' opinions on BLUEPRINT MEDICINES CORP future price: according to them, 1BPMC price has a max estimate of 147.95 EUR and a min estimate of 73.53 EUR. Watch 1BPMC chart and read a more detailed BLUEPRINT MEDICINES CORP stock forecast: see what analysts think of BLUEPRINT MEDICINES CORP and suggest that you do with its stocks.
1BPMC reached its all-time high on May 2, 2025 with the price of 89.52 EUR, and its all-time low was 75.82 EUR and was reached on Apr 25, 2025. View more price dynamics on 1BPMC chart.
See other stocks reaching their highest and lowest prices.
1BPMC stock is 12.78% volatile and has beta coefficient of 1.37. Track BLUEPRINT MEDICINES CORP stock price on the chart and check out the list of the most volatile stocks — is BLUEPRINT MEDICINES CORP there?
Yes, you can track BLUEPRINT MEDICINES CORP financials in yearly and quarterly reports right on TradingView.
BLUEPRINT MEDICINES CORP is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1BPMC earnings for the last quarter are 0.0092 EUR per share, whereas the estimation was −0.45 EUR resulting in a 102.06% surprise. The estimated earnings for the next quarter are −0.41 EUR per share. See more details about BLUEPRINT MEDICINES CORP earnings.
BLUEPRINT MEDICINES CORP revenue for the last quarter amounts to ‪138.11 M‬ EUR, despite the estimated figure of ‪143.72 M‬ EUR. In the next quarter, revenue is expected to reach ‪151.67 M‬ EUR.
1BPMC net income for the last quarter is ‪458.47 K‬ EUR, while the quarter before that showed ‪−48.26 M‬ EUR of net income which accounts for 100.95% change. Track more BLUEPRINT MEDICINES CORP financial stats to get the full picture.
No, 1BPMC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 4, 2025, the company has 649 employees. See our rating of the largest employees — is BLUEPRINT MEDICINES CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BLUEPRINT MEDICINES CORP EBITDA is ‪−146.39 M‬ EUR, and current EBITDA margin is −38.47%. See more stats in BLUEPRINT MEDICINES CORP financial statements.
Like other stocks, 1BPMC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BLUEPRINT MEDICINES CORP stock right from TradingView charts — choose your broker and connect to your account.